American Bioscience Gains FDA Approval For Abraxane Jan. 11, 2005 Providing new hope for breast cancer patients, Abraxane soon will offer the antitumor benefits, without the toxic solvent side effects, of paclitaxel. (BioWorld Today)Read More
RSS